FDA Recalls Blood Pressure Medication for Contaminant Linked to Cancer

By Sarah King

Oct 31

FDA Recalls Blood Pressure Medication for Contaminant Linked to Cancer

Another blood pressure medication is being taken off pharmacy shelves for cancer-causing contaminants. The most recent recall is for blood pressure medication Quinapril and Hydrochlorothiazide tablets produced by Aurobindo Pharma USA, Inc.

The medication’s contaminant is N-Nitroso-Quinapril, which exceeds the dosage’s acceptable limit, and can lead to cancer.

It is important to note that if you are currently prescribed and taking this medication, consult with your physician as soon as possible. Stopping your blood pressure medication abruptly can put you at risk of a heart attack or other injury.

The Philadelphia personal injury attorneys at Messa & Associates are experienced at handling cases involving pharmaceutical and drug product injuries from defective products. Our extremely skilled team of personal injury attorneys and medical experts is dedicated to ensuring you receive proper compensation for your personal injuries. If you have been injured by a blood pressure medication or any other pharmaceutical drug or have endured any other type of personal injury, contact the personal injury attorneys of Messa & Associates for a free consultation. Call toll-free at 1-877-MessaLaw, or submit a free online inquiry.

-$20 Million total settlement for clients injured as a result of ingestion of the diet drug Fen-Phen

-$10.9 Million verdict for Haley Powell, a South Carolina woman who used Topamax from about March 2006 to about May 2011 including during her pregnancy. Powell’s son, Brayden Gurley, was born with a cleft lip in 2008. The verdicts are the first two of more than 130 cases filed against Janssen Pharmaceuticals in the Philadelphia Court of Common Pleas.

About the Author